{"id":{"repo_id":"ncsu","oai_identifier":"oai:repository.lib.ncsu.edu:1840.16/5768"},"canonical_url":"https://search.dev.ndltd.org/etd/ncsu/oai:repository.lib.ncsu.edu:1840.16/5768","repository":{"repo_id":"ncsu","name":"North Carolina State University","base_url":"https://repository.lib.ncsu.edu/server/oai/request"},"display":{"title":"Statistical Analysis in Two Stage Randomization Designs in Clinical Trials","abstract":"Two-stage randomization designs are becoming more common in many clinical trials related to diseases such as cancer and HIV, where an induction therapy is given followed by a maintenance therapy depending on patients' response and consent. The main interest is to compare combinations of induction and maintenance therapies and to find the combination leading to the longest average survival time. However, in practice, the data analysis is typically conducted separately in two stages. In this Thesis, we tackle the problem based on treatment policies. We use the concepts of counting process and risk set as described by Fleming and Harrington (1991) to find weighted estimating equations whose solution gives an estimator for the cumulative hazard function which, in turn, is used to derive an estimator for the overall survival distribution under a treatment policy with right-censored data. We call this estimator as the Weighted Risk Set Estimator (WRSE). We show that the WRSE is consistent and asymptotically normally distributed. In addition to survival distribution estimation, we also consider the hypothesis testing problem. Since the log rank test is the common method for hypothesis testing in survival analysis, we propose a test statistic using an inverse weighted version of the log rank test. We use simulation studies to demonstrate the properties of our method and use data from a clinical trial, Protocol 88923, conducted by the Cancer and Leukemia Group B (CALGB) to illustrate how to implement the method.","abstract_html":"Two-stage randomization designs are becoming more common in many clinical trials related to diseases such as cancer and HIV, where an induction therapy is given followed by a maintenance therapy depending on patients' response and consent. The main interest is to compare combinations of induction and maintenance therapies and to find the combination leading to the longest average survival time. However, in practice, the data analysis is typically conducted separately in two stages. In this Thesis, we tackle the problem based on treatment policies. We use the concepts of counting process and risk set as described by Fleming and Harrington (1991) to find weighted estimating equations whose solution gives an estimator for the cumulative hazard function which, in turn, is used to derive an estimator for the overall survival distribution under a treatment policy with right-censored data. We call this estimator as the Weighted Risk Set Estimator (WRSE). We show that the WRSE is consistent and asymptotically normally distributed. In addition to survival distribution estimation, we also consider the hypothesis testing problem. Since the log rank test is the common method for hypothesis testing in survival analysis, we propose a test statistic using an inverse weighted version of the log rank test. We use simulation studies to demonstrate the properties of our method and use data from a clinical trial, Protocol 88923, conducted by the Cancer and Leukemia Group B (CALGB) to illustrate how to implement the method.","abstract_has_math":false,"creators":["Guo, Xiang"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Daowen Zhang, Committee Member","John Monahan, Committee Member","Marie Davidian, Committee Member","Anastasios A. Tsiatis, Committee Chair"],"committee_chairs":[],"committee_members":[],"year":2005,"date_issued":"2005-06-25","date_published":"2005-06-25","updated_at":"2026-08-21T22:21:56Z","subjects":["clinical trials","counting process","risk set","survival analysis","two stage randomization design"],"languages":[],"rights":["I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to NC State University or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report."],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["etd-06232005-143538"],"render_values":[{"text":"etd-06232005-143538","href":null,"code":true}]}]},"links":{"outbound_url":"http://www.lib.ncsu.edu/resolver/1840.16/5768","outbound_label":"Repository record","outbound_source":"dc:identifier.uri"},"source_record":{"url":"https://repository.lib.ncsu.edu/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Arepository.lib.ncsu.edu%3A1840.16%2F5768","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Daowen Zhang, Committee Member","John Monahan, Committee Member","Marie Davidian, Committee Member","Anastasios A. Tsiatis, Committee Chair"]},{"key":"dc:creator","label":"Author","values":["Guo, Xiang"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2010-04-02T19:19:35Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2010-04-02T19:19:35Z"]},{"key":"dc:date.issued","label":"Date","values":["2005-06-25"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["clinical trials","counting process","risk set","survival analysis","two stage randomization design"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights","label":"Dc Rights","values":["I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to NC State University or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["etd-06232005-143538"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://www.lib.ncsu.edu/resolver/1840.16/5768"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["North Carolina State University Theses Statistics.;North Carolina State University Statistics Theses."]},{"key":"dc:description.abstract","label":"Abstract","values":["Two-stage randomization designs are becoming more common in many clinical trials related to diseases such as cancer and HIV, where an induction therapy is given followed by a maintenance therapy depending on patients' response and consent. The main interest is to compare combinations of induction and maintenance therapies and to find the combination leading to the longest average survival time. However, in practice, the data analysis is typically conducted separately in two stages. In this Thesis, we tackle the problem based on treatment policies. We use the concepts of counting process and risk set as described by Fleming and Harrington (1991) to find weighted estimating equations whose solution gives an estimator for the cumulative hazard function which, in turn, is used to derive an estimator for the overall survival distribution under a treatment policy with right-censored data. We call this estimator as the Weighted Risk Set Estimator (WRSE). We show that the WRSE is consistent and asymptotically normally distributed. In addition to survival distribution estimation, we also consider the hypothesis testing problem. Since the log rank test is the common method for hypothesis testing in survival analysis, we propose a test statistic using an inverse weighted version of the log rank test. We use simulation studies to demonstrate the properties of our method and use data from a clinical trial, Protocol 88923, conducted by the Cancer and Leukemia Group B (CALGB) to illustrate how to implement the method."]},{"key":"dc:format","label":"Dc Format","values":["Thesis (Ph.D.)--North Carolina State University."]},{"key":"dc:title","label":"Title","values":["Statistical Analysis in Two Stage Randomization Designs in Clinical Trials"]}]}],"canonical_facts":{"dc:contributor.advisor":["Daowen Zhang, Committee Member","John Monahan, Committee Member","Marie Davidian, Committee Member","Anastasios A. Tsiatis, Committee Chair"],"dc:creator":["Guo, Xiang"],"dc:date.accessioned":["2010-04-02T19:19:35Z"],"dc:date.available":["2010-04-02T19:19:35Z"],"dc:date.issued":["2005-06-25"],"dc:description":["North Carolina State University Theses Statistics.;North Carolina State University Statistics Theses."],"dc:description.abstract":["Two-stage randomization designs are becoming more common in many clinical trials related to diseases such as cancer and HIV, where an induction therapy is given followed by a maintenance therapy depending on patients' response and consent. The main interest is to compare combinations of induction and maintenance therapies and to find the combination leading to the longest average survival time. However, in practice, the data analysis is typically conducted separately in two stages. In this Thesis, we tackle the problem based on treatment policies. We use the concepts of counting process and risk set as described by Fleming and Harrington (1991) to find weighted estimating equations whose solution gives an estimator for the cumulative hazard function which, in turn, is used to derive an estimator for the overall survival distribution under a treatment policy with right-censored data. We call this estimator as the Weighted Risk Set Estimator (WRSE). We show that the WRSE is consistent and asymptotically normally distributed. In addition to survival distribution estimation, we also consider the hypothesis testing problem. Since the log rank test is the common method for hypothesis testing in survival analysis, we propose a test statistic using an inverse weighted version of the log rank test. We use simulation studies to demonstrate the properties of our method and use data from a clinical trial, Protocol 88923, conducted by the Cancer and Leukemia Group B (CALGB) to illustrate how to implement the method."],"dc:format":["Thesis (Ph.D.)--North Carolina State University."],"dc:identifier.other":["etd-06232005-143538"],"dc:identifier.uri":["http://www.lib.ncsu.edu/resolver/1840.16/5768"],"dc:rights":["I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to NC State University or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report."],"dc:subject":["clinical trials","counting process","risk set","survival analysis","two stage randomization design"],"dc:title":["Statistical Analysis in Two Stage Randomization Designs in Clinical Trials"]},"updated_at":"2026-08-21T22:21:56Z"}